|
TBC1D14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.25300003284946E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.158700E-04 |
| Normal-vs-Stage2 |
9.224800E-01 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.575200E-01 |
| Stage1-vs-Stage3 |
1.96083999999264E-05 |
| Stage1-vs-Stage4 |
7.96120000000622E-05 |
| Stage2-vs-Stage3 |
5.954300E-02 |
| Stage2-vs-Stage4 |
6.724300E-02 |
| Stage3-vs-Stage4 |
6.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.60859999554353E-08 |
| Normal-vs-AfricanAmerican |
2.296400E-02 |
| Normal-vs-Asian |
1.98362999999091E-05 |
| Caucasian-vs-AfricanAmerican |
6.914400E-01 |
| Caucasian-vs-Asian |
6.192500E-02 |
| AfricanAmerican-vs-Asian |
1.194410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.4134000000029E-05 |
| Normal-vs-Female |
2.89190005275941E-10 |
| Male-vs-Female |
3.615600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.606160E-01 |
| Normal-vs-Age(41-60Yrs) |
7.683800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.73470135425669E-11 |
| Normal-vs-Age(81-100Yrs) |
4.60040006089457E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.647000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.252200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.169600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.309820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.143900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.213000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.55699999851933E-08 |
| Normal-vs-Grade 2 |
7.56310000000759E-05 |
| Normal-vs-Grade 3 |
3.07519998354877E-09 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
3.807400E-01 |
| Grade 1-vs-Grade 3 |
8.755600E-01 |
| Grade 1-vs-Grade 4 |
2.687600E-02 |
| Grade 2-vs-Grade 3 |
3.462200E-01 |
| Grade 2-vs-Grade 4 |
2.082300E-03 |
| Grade 3-vs-Grade 4 |
1.811930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
5.882600E-01 |
| ccA subtype-vs-ccB subtype |
1.125670E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.503290E-03 |
| Normal-vs-N1 |
3.07230000329284E-08 |
| N0-vs-N1 |
4.673600E-02 |
|
|
